Osborn Rohs Williams Donohoe Ltd Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Osborn Rohs Williams Donohoe Ltd reduced its stake in Stryker Corporation by 2.2% during the most recent quarter end. The investment management company now holds a total of 92,363 shares of Stryker Corporation which is valued at $10,141,457 after selling 2,082 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Apr 14, 2016.Stryker Corporation makes up approximately 2.01% of Osborn Rohs Williams Donohoe Ltd’s portfolio.

Stryker Corporation opened for trading at $109.76 and hit $110.52 on the upside on Monday, eventually ending the session at $110.39, with a gain of 0.54% or 0.59 points. The heightened volatility saw the trading volume jump to 10,39,660 shares. Company has a market cap of $41,174 M.

Other Hedge Funds, Including , Bremer Trust National Association boosted its stake in SYK in the latest quarter, The investment management firm added 288 additional shares and now holds a total of 14,843 shares of Stryker Corporation which is valued at $1,629,761. Stryker Corporation makes up approx 0.46% of Bremer Trust National Association’s portfolio.First Financial Bank N.a. – Trust Division boosted its stake in SYK in the latest quarter, The investment management firm added 1,794 additional shares and now holds a total of 40,873 shares of Stryker Corporation which is valued at $4,424,502. Stryker Corporation makes up approx 0.88% of First Financial Bank N.a. – Trust Division’s portfolio.Renaissance Investment Group reduced its stake in SYK by selling 47 shares or 1.68% in the most recent quarter. The Hedge Fund company now holds 2,745 shares of SYK which is valued at $297,887. Stryker Corporation makes up approx 0.15% of Renaissance Investment Group’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.56 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 26, 2016. Analyst had a consensus of $1.55. The company had revenue of $2715.00 million for the quarter, compared to analysts expectations of $2714.84 million. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.Stryker Corporation was Initiated by Nomura to “Neutral” on Mar 17, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.